Entinostat (MS-275)
 
       商品编号:
        
         TS0068
         
        
        
       
       
       
      
         
          
备注:
 如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
          
       
       
       
       
        
        
详细介绍
 
       
              
          | l  基本信息 | 
| 产品名称 | 恩替诺特(Entinostat (MS-275)) | 
| 一般描述 | Entinostat(恩替诺特) is a synthetic benzamide derivative with potential antineoplastic activity. | 
| 别 称 | pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate; SNDX-275 | 
| 纯 度 | ≥98.0%(HPLC) | CAS NO. | 209783-80-2 | 
| 分子式 | C21H20N4O3 | 分子量 | 376.41 | 
| 适用范围 | 生物试剂,适用于细胞培养等 | 
| l  理化信息 | 
| 外 观 | 固体 | 
| 溶解性(25℃) | DMSO | ≥50mg/mL | 
| 乙醇 | Insoluble | 
| 水 | Insoluble | 
| l  生物学信息 | 
| 生物活性/药理作用 | Entinostat is a synthetic benzamide derivative with potential antineoplastic activity. Entinostat binds to and inhibits histone deacetylase, an enzyme that regulates chromatin structure and gene tranion. This agent appears to exert dose-dependent effects in human leukemia cells including cyclin-dependent kinase inhibitor 1A (p21/CIP1/WAF1)-dependent growth arrest and differentiation at low drug concentrations; a marked induction of reactive oxygen species (ROS); mitochondrial damage; caspase activation; and, at higher concentrations, apoptosis. In normal cells, cyclin-dependent kinase inhibitor 1A has been associated with cell-cycle exit and differentiation. Entinostat strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 μM and 1.7 μM in cell-free assays, compared with HDACs 4, 6, 8, and 10. | 
| l  存储 | 
| 存储温度 | -20℃ | 
| l  注意事项及免责声明 | 
| 本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。 | 
| l  参考文献 | 
| 1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov |